v1
Teniposide (VM-26), an overlooked highly active agent in small-cell lung cancer. Results of a phase II trial in untreated patients.
Identifier:nobleid.org/w1/20260515/8F07FD75
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/8F07FD75)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims